Pro zobrazení tohoto obsahu je třeba být přihlášen.
Categories for Uncategorized
KEYNOTE-164: Pembrolizumab for patients with advanced microsatellite instability high (MSI-H) colorectal cancer
23 septembra, 2020 4:52 pmMeeting: 2018 ASCO Annual Meeting Track: Gastrointestinal (Colorectal) Cancer Abstract number: 3514 Authors: Dung T. Le, Petr...
High-Dose Acid Suppression for Preventing Esophageal Adenocarcinoma in Patients With Metaplasia
23 septembra, 2020 4:52 pmJune 4, 2018 Adjuvant chemotherapy with a modified FOLFIRINOX (mFOLFIRINOX) regimen was superior to gemcitabine with regard to disease-free,...
Chemoprevention of esophageal cancer with esomeprazole and aspirin therapy: Efficacy and safety in the phase III randomized factorial ASPECT trial
23 septembra, 2020 4:52 pmMeeting: 2018 ASCO Annual Meeting Track: Gastrointestinal (Noncolorectal) Cancer Abstract number: LBA4008 Authors: Janusz Jankowski, John de...
High-Dose Acid Suppression for Preventing Esophageal Adenocarcinoma in Patients With Metaplasia
23 septembra, 2020 4:52 pmJune 4, 2018 A high dose of a proton-pump inhibitor (PPI) combined with low-dose aspirin reduced the risk of...
Najvýznamnejšie klinické správy z konferencie ASCO 2018 v problematike nádorov gastrointestinálneho traktu
23 septembra, 2020 4:52 pmPočas prvého júnového týždňa tohto roka sa konal v Chicagu tradičný výročný kongres Americkej onkologickej spoločnosti (ASCO). Ako obvykle v rámci prednášok...
Overall survival in COLUMBUS: A phase 3 trial of encorafenib (ENCO) plus binimetinib (BINI) vs vemurafenib (VEM) or enco in BRAF-mutant melanoma
23 septembra, 2020 4:52 pmMeeting: 2018 ASCO Annual Meeting Track: Melanoma/Skin Cancers Abstract number: 9504 Authors: Reinhard Dummer, Paolo Antonio Ascierto,...
Anti-PD1 antibodies in late elderly advanced melanoma patients: A retrospective multicentre study
23 septembra, 2020 4:52 pmMeeting: 2018 ASCO Annual Meeting Track: Patient and Survivor Care Abstract number: 10 038 Authors: Francesco De Rosa,...
Characterization of complete responders to combination nivolumab (nivo) and ipilimumab (ipi) in patients (pts) with advanced, unresectable melanoma
23 septembra, 2020 4:52 pmMeeting: 2018 ASCO Annual Meeting Track: Melanoma/Skin Cancers Abstract number: 9552 Authors: Allison Betof Warner, Alexander Noor...
Four-Year Data Show Durable Effect of Pembrolizumab in Advanced Melanoma
23 septembra, 2020 4:52 pmJune 4, 2018 The anti–PD-1 antibody pembrolizumab previously demonstrated superior overall survival (OS) in patients with advanced melanoma compared...
Nivolumab (Nivo) as neoadjuvant therapy in patients with resectable Merkel cell carcinoma (MCC) in CheckMate 358
23 septembra, 2020 4:52 pmMeeting: 2018 ASCO Annual Meeting Track: Melanoma/Skin Cancers Abstract number: 9505 Authors: Suzanne Louise Topalian, Shailender Bhatia,...